Effect of tibenelast (a phosphodiesterase inhibitor) and theophylline on isoproterenol-stimulated heart rate, cyclic AMP and norepinephrine levels.
The effect of the phosphodiesterase inhibitors (tibenelast, theophylline) and placebo on isoproterenol-induced changes in heart rate, cAMP and norepinephrine levels in normal male volunteers was studied. Heart rates in response to isoproterenol dosing were fitted by linear regression, and horizontal shifts in the regression lines were examined between the three treatments. The shift of the regression line after placebo compared to the preplacebo line was to the right by 2.6 +/- 2.2 ng ISO/kg/min, theophylline pretreatment shifted this line to the left by 2.4 +/- 1.8 ng/kg/min (p < 0.05) and tibenelast by 3.7 +/- 1.9 ng/kg/min (p < 0.02). Both tibenelast and theophylline increased the heart rate response to isoproterenol infusion, whereas norepinephrine and cAMP levels were not different in any treatment.
Schwertschlag
U S
US
Lilly Laboratory for Clinical Research, Indianapolis, Ind. 46202.
Cerimele
B J
BJ
McNay
J L
JL
Bowsher
R R
RR
Rowe
H
H
D000328:Adult; D001794:Blood Pressure / Q000187:drug effects; D000242:Cyclic AMP / Q000097:blood* / Q000652:urine; D004305:Dose-Response Relationship, Drug; D006339:Heart Rate / Q000187:drug effects*; D006801:Humans; D007545:Isoproterenol / Q000494:pharmacology; D008297:Male; D008875:Middle Aged; D009638:Norepinephrine / Q000097:blood* / Q000652:urine; D010726:Phosphodiesterase Inhibitors / Q000494:pharmacology*; D012044:Regression Analysis; D013806:Theophylline / Q000008:administration & dosage / Q000494:pharmacology*; D013876:Thiophenes / Q000008:administration & dosage / Q000494:pharmacology*
D010726:Phosphodiesterase Inhibitors; D013876:Thiophenes; D013806:Theophylline; D000242:Cyclic AMP; C063779:tibenelast; D007545:Isoproterenol; D009638:Norepinephrine